This study in the New England Journal of Medicine isn't even about Ervebo. You would know that if you'd read any of this. Sure, sure, because it would have the name Ervebo in it. Or not. Or you should know this from the headline because here's that headline. A randomized controlled trial of Ebola virus disease therapeutics. This is about therapeutics. Right. Like monoclonal antibodies and antiviral agents. Things to do after you. It's not at all about vaccines. Not preventing it.